TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8203683

Group type: EXPERIMENTAL
Intervention: Medicaid prepaid plan (HMO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fee-for-service Medicaid
Number of subjects: 0
Study: 3119024

Group type: EXPERIMENTAL
Intervention: Socioeconomic factors (measured through census data)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Standardised mortality ratios
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Direct relation for women without reference to husbands' occupations
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Data analysis
Number of subjects: 78
Study: 31165607

Group type: EXPERIMENTAL
Intervention: High quality nursing intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional nursing
Number of subjects: 96
Study: 28797454

Group type: EXPERIMENTAL
Intervention: Early feeding intervention via prophylactic gastrostomy tube (PGT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual care (feeding commenced when clinically indicated)
Number of subjects: 124
Study: 25712585

Group type: EXPERIMENTAL
Intervention: Cobedding (twins cared for in a single cot)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Standard care (twins cared for in separate cots)
Number of subjects: 234
Study: 24239201

Group type: EXPERIMENTAL
Intervention: Clopidogrel with CYP3A4-metabolized statin
Number of subjects: 6795

Group type: EXPERIMENTAL
Intervention: Clopidogrel with calcium-channel blockers (CCBs)
Number of subjects: 6795

Group type: EXPERIMENTAL
Intervention: Clopidogrel with CCB and atorvastatin 80 mg daily
Number of subjects: 6795

Group type: EXPERIMENTAL
Intervention: Clopidogrel with CCB, statin, and proton pump inhibitor
Number of subjects: 6795

Group type: COMPARATOR
Intervention: Prasugrel versus clopidogrel
Number of subjects: 6795
Study: 21485018

Group type: EXPERIMENTAL
Intervention: Standardized informed consent and a paper handout detailing the risks/benefits of TKA
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Standardized informed consent, a paper handout, and a video discussing the risks/benefits of TKA
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Standardized informed consent, a paper handout, a video discussing the risks/benefits of TKA, plus formal nurse education
Number of subjects: 151

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 151
Study: 19062238

Group type: EXPERIMENTAL
Intervention: Free home-pregnancy test kit
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (no home-pregnancy test kit)
Number of subjects: 198
Study: 16579708

Group type: EXPERIMENTAL
Intervention: Bioabsorbable barrier (polyglactin 910; T)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Non-resorbable barrier (ePTFE; C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both groups (C and T)
Number of subjects: 9
Study: 12720542

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone 400 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone 800 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10671841

Group type: EXPERIMENTAL
Intervention: Zipprep electrodes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrocardiogram electrodes
Number of subjects: 0
Study: 9142771

Group type: EXPERIMENTAL
Intervention: Extended-interval dosing of aminoglycosides
Number of subjects: 22
Study: 8457446

Group type: EXPERIMENTAL
Intervention: Corticosteroid (betamethasone-17-valerate)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drug (indomethacin)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Antihistamine (diphenhydramine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 10
Study: 31719278

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with the median approach (Group M)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with the paramedian approach (Group PM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 200
Study: 28885881

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 713

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study: 26162850

Group type: EXPERIMENTAL
Intervention: GVXN SD133 vaccine (2 μg with or without aluminium adjuvant)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GVXN SD133 vaccine (10 μg with or without aluminium adjuvant)
Number of subjects: 40

Group type: COMPARATOR
Intervention: GVXN SD133 vaccine (2 μg or 10 μg)
Number of subjects: 40
Study: 23329618

Group type: EXPERIMENTAL
Intervention: Educational programme to improve falling skills during physical education classes
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular physical education curriculum (Control)
Number of subjects: 33
Study: 21764693

Group type: EXPERIMENTAL
Intervention: Monitored Anesthesia Care (MAC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 30
Study: 18362236

Group type: EXPERIMENTAL
Intervention: Matrix-array 3-dimensional echocardiography (3DE)
Number of subjects: 29
Study: 16939923

Group type: EXPERIMENTAL
Intervention: remifentanil by TCI at 2 ng/ml and propofol 1mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: remifentanil by TCI, propofol, and doxapram 0.6 mg/kg
Number of subjects: 120
Study: 12871872

Group type: EXPERIMENTAL
Intervention: Step-up protocol using recombinant FSH (Puregon)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Step-down protocol using recombinant FSH (Puregon)
Number of subjects: 83
Study: 11078902

Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 6

Group type: COMPARATOR
Intervention: Proprioceptive feedback
Number of subjects: 6
Study: 9010744

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 50 micrograms + medroxyprogesterone 10 mg/day for 12 days
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens, 0.625 mg/day + medroxyprogesterone acetate 10 mg/day for 12 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 42
Study: 1389931

Group type: EXPERIMENTAL
Intervention: 12.5 mg venlafaxine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 25 mg venlafaxine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 50 mg venlafaxine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All doses of venlafaxine
Number of subjects: 16
Study: 4065165

Group type: EXPERIMENTAL
Intervention: Prone position with head tilted down at 10 degrees for 30 min after LP
Number of subjects: 160

Group type: COMPARATOR
Intervention: Upright position immediately after LP
Number of subjects: 160
Study: 29534487

Group type: EXPERIMENTAL
Intervention: Pecan-rich diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet (isocaloric, similar in total fat and fiber content, absent nuts)
Number of subjects: 0
Study: 26828426

Group type: EXPERIMENTAL
Intervention: Progressive resistance-training intervention during radiation treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Progressive resistance-training intervention after radiation treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions (during and after treatment)
Number of subjects: 60
Study: 24104856

Group type: EXPERIMENTAL
Intervention: 4-h interactive evidence-based educational programme
Number of subjects: 192

Group type: COMPARATOR
Intervention: 4-h MS-specific stress management programme
Number of subjects: 192
Study: 22743626

Group type: EXPERIMENTAL
Intervention: Fistula ligation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Patent fistula (control group)
Number of subjects: 18
Study: 20487612

Group type: EXPERIMENTAL
Intervention: Latent tuberculosis infection (LTBI) screening and treatment
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Risk factors for TB
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Population risk attributable to race and HIV
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Cluster analysis of TB cases
Number of subjects: 447
Study: 16775817

Group type: EXPERIMENTAL
Intervention: Axillary padding without a drain
Number of subjects: 100

Group type: COMPARATOR
Intervention: Axillary suction drain
Number of subjects: 100
Study: 14977778

Group type: EXPERIMENTAL
Intervention: Isoxic hypercapnia (end tidal PCO(2) increased 15% above baseline)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hyperoxia (100% oxygen breathing)
Number of subjects: 28
Study: 11564183

Group type: EXPERIMENTAL
Intervention: Sangre de grado balm (1% concentration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sangre de grado balm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sangre de grado balm (Zangrado)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highly diluted sangre de grado (1:10,000)
Number of subjects: 0
Study: 9215935

Group type: EXPERIMENTAL
Intervention: Ergonomic-educational course
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no course)
Number of subjects: 24
Study: 8095558

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 3322096

Group type: EXPERIMENTAL
Intervention: i.v. meptazinol 2 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: i.v. meptazinol 4 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo)
Number of subjects: 80
Study: 31433669

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg and 200 mg
Number of subjects: 1978
Study: 28196208

Group type: EXPERIMENTAL
Intervention: Single 8-Gy radiotherapy dose for 1 or 2 bone metastases
Number of subjects: 298
Study: 25659986

Group type: EXPERIMENTAL
Intervention: Aprepitant (Emend®) plus standard antiemetics
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo plus standard antiemetics
Number of subjects: 96
Study: 24142756

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Rosuvastatin
Number of subjects: 90
Study: 22642610

Group type: EXPERIMENTAL
Intervention: Structured educational programme (3 hour session) promoting physical activity and healthy lifestyle, with annual group-based maintenance workshops and telephone contact.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Advice leaflet (control group).
Number of subjects: 10
Study: 19528854

Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion (CHO, 0.5 g of CHO per 18 capsules, approximately 0.13 g x kg(‐1) of body weight)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo ingestion (PLAC, gelatin, 0.5 g per 18 capsules, approximately 0.13 g x kg(‐1) of body weight)
Number of subjects: 9
Study: 17391920

Group type: EXPERIMENTAL
Intervention: Negative sensations only (hypoaesthetic)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Mixed sensations (negative+active)
Number of subjects: 184

Group type: COMPARATOR
Intervention: No altered sensation
Number of subjects: 184
Study: 16220649

Group type: EXPERIMENTAL
Intervention: Training course on managing patient aggression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no training course)
Number of subjects: 0
Study: 12376849

Group type: EXPERIMENTAL
Intervention: Propofol (0.6 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: S-ketamin (0.3 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamin (0.6 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.5 microgram/kg)
Number of subjects: 60
Study: 9925042

Group type: EXPERIMENTAL
Intervention: Interactive intervention (stage‐matched expert‐system reports plus manuals)
Number of subjects: 4653

Group type: COMPARATOR
Intervention: Noninteractive intervention (stage‐matched manuals)
Number of subjects: 4653
Study: 7488690

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet plus serotoninergic medication
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 60
Study: 2209079

Group type: EXPERIMENTAL
Intervention: Urea compound
Number of subjects: 10

Group type: COMPARATOR
Intervention: Emollient cream
Number of subjects: 10
Study: 6257799

Group type: EXPERIMENTAL
Intervention: Aqueous iodine (2%) applied to fingers
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (placebo preparation)
Number of subjects: 15
Study: 24970720

Group type: COMPARATOR
Intervention: iCBT self‐help format (iCBT‐S)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: iCBT group‐therapy format (iCBT‐G)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 45
Study: 25833209

Group type: EXPERIMENTAL
Intervention: Vitamin D levels (continuous and categorical)
Number of subjects: 2104
Study: 23311404

Group type: EXPERIMENTAL
Intervention: Oral paricalcitol
Number of subjects: 66

Group type: COMPARATOR
Intervention: Oral calcitriol
Number of subjects: 66
Study: 20708275

Group type: EXPERIMENTAL
Intervention: Poor sleep quality (measured by Pittsburgh Sleep Quality Index - PSQI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Hormonal measures (Estradiol, Prolactin, Cortisol) and IL-6
Number of subjects: 56
Study: 18725656

Group type: EXPERIMENTAL
Intervention: Walk in the park (20 minutes)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Downtown walk (20 minutes)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Neighborhood walk (20 minutes)
Number of subjects: 17
Study: 17177665

Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine (group 1)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.4% benoxinate followed by 2.5% phenylephrine (group 2)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 44
Study: 14963679

Group type: EXPERIMENTAL
Intervention: Occupational integrated rehabilitation program (2.5-3 hours twice a week for 15 weeks according to BAR guidelines) with annual check-ups.
Number of subjects: 40000

Group type: COMPARATOR
Intervention: Evidence-based treatment in cooperation with general practitioner (GP).
Number of subjects: 40000

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 40000
Study: 12131291

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid fluorescence endoscopy
Number of subjects: 129

Group type: COMPARATOR
Intervention: White light endoscopy
Number of subjects: 129
Study: 9602583

Group type: EXPERIMENTAL
Intervention: HBOC‐201 0.4 g kg‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: HES 3 ml kg‐1
Number of subjects: 12
Study: 8031049

Group type: EXPERIMENTAL
Intervention: Levofloxacin 350 mg orally every 8 hours for one week
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2746448

Group type: EXPERIMENTAL
Intervention: active antimicrobial mouthrinse
Number of subjects: 99

Group type: COMPARATOR
Intervention: control mouthrinse
Number of subjects: 99
Study: 909027

Group type: EXPERIMENTAL
Intervention: Topical application of povidone iodine on umbilical cord and normal intact skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical application of povidone iodine on denuded skin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical application of povidone iodine
Number of subjects: 0
Study: 30978622

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy (PE)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy (PE) and Relaxation Training (RT)
Number of subjects: 87
Study: 29122072

Group type: EXPERIMENTAL
Intervention: CHX containing GIC
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CHX cavity disinfection
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional GIC
Number of subjects: 90
Study: 1447501

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (50 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 22844045

Group type: EXPERIMENTAL
Intervention: High-flexion rotating-platform posterior-stabilised design (RP-F)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard fixed-bearing posterior cruciate ligament-preserving design (FB-S)
Number of subjects: 77
Study: 20060078

Group type: EXPERIMENTAL
Intervention: teriparatide 20 mug/day by subcutaneous injection
Number of subjects: 197

Group type: COMPARATOR
Intervention: alendronate 10 mg/day orally
Number of subjects: 197
Study: 18689571

Group type: EXPERIMENTAL
Intervention: 15 g resistant maltodextrin
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 7.5 g maltodextrin plus 7.5 g resistant maltodextrin
Number of subjects: 38

Group type: COMPARATOR
Intervention: 15 g maltodextrin
Number of subjects: 38
Study: 16739679

Group type: EXPERIMENTAL
Intervention: Random practice schedule
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blocked practice schedule
Number of subjects: 0
Study: 12689733

Group type: EXPERIMENTAL
Intervention: Radioactive iodine tagged with lipiodol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 10674014

Group type: EXPERIMENTAL
Intervention: MLT (20 mg/day orally every day) plus chemotherapy
Number of subjects: 250

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 250
Study: 8932544

Group type: EXPERIMENTAL
Intervention: PEG-liposomal doxorubicin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard doxorubicin
Number of subjects: 18
Study: 2006741

Group type: EXPERIMENTAL
Intervention: 1% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 200 mg ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100 mg ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bromage scale
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quantitative method for motor blockade
Number of subjects: 30
Study: 6137468

Group type: EXPERIMENTAL
Intervention: Pindolol (beta-adrenergic antagonist)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31674060

Group type: EXPERIMENTAL
Intervention: 4 mg of prolonged-release melatonin (Circadin), ingested orally once-daily before bedtime
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched placebo, ingested orally once-daily before bedtime
Number of subjects: 30
Study: 30956109

Group type: EXPERIMENTAL
Intervention: Group-administered Cognitive Behavioral Therapy (CBT) for 7 weeks
Number of subjects: 137

Group type: COMPARATOR
Intervention: Waitlist control receiving the intervention after 8 weeks
Number of subjects: 137
Study: 30479202

Group type: COMPARATOR
Intervention: Standard MTM (SMTM)
Number of subjects: 342

Group type: COMPARATOR
Intervention: MTM incorporating clinical decision support tool (CMTM)
Number of subjects: 342

Group type: COMPARATOR
Intervention: CMTM enhanced by pharmacogenetic test results (PGxMTM)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: PGxMTM
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: All DTPs
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: DTPs from PGxMTM arm
Number of subjects: 342
Study: 26938989

Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 100
Study: 24144880

Group type: EXPERIMENTAL
Intervention: 2000 lux light exposure
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 8000 lux light exposure
Number of subjects: 45

Group type: COMPARATOR
Intervention: Older adults baseline phase
Number of subjects: 45
Study: 22578834

Group type: EXPERIMENTAL
Intervention: Low dose CTCA using SAFIRE (protocol B)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard dose CTCA using FBP (protocol A)
Number of subjects: 78
Study: 19325451

Group type: EXPERIMENTAL
Intervention: PHiD-CV
Number of subjects: 806

Group type: COMPARATOR
Intervention: 7vCRM
Number of subjects: 806
Study: 17170385

Group type: EXPERIMENTAL
Intervention: AVE5883 (4.8 mg single inhaled dose)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AVE5883 (4.8 mg three times per day for 9 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 16729384

Group type: EXPERIMENTAL
Intervention: Sensorimotor Training followed by High-Intensity Strength Training (SMT-HST)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-Intensity Strength Training followed by Sensorimotor Training (HST-SMT)
Number of subjects: 18
Study: 15067647

Group type: EXPERIMENTAL
Intervention: Cryotherapy group fitted with a computer-controlled cooling device for 4 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no cryotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryotherapy group
Number of subjects: 0
Study: 10800819

Group type: EXPERIMENTAL
Intervention: On-pump CABG with CPB and cardioplegic arrest
Number of subjects: 60

Group type: COMPARATOR
Intervention: Off-pump CABG on the beating heart
Number of subjects: 60
Study: 8969391

Group type: EXPERIMENTAL
Intervention: Propofol-alfentanil anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane anesthesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Inhalation anesthesia
Number of subjects: 30
Study: 1595776

Group type: EXPERIMENTAL
Intervention: Insulin plus 10 mg glyburide before breakfast
Number of subjects: 21

Group type: COMPARATOR
Intervention: Insulin-only group
Number of subjects: 21
Study: 3967459

Group type: EXPERIMENTAL
Intervention: Propranolol (240 mg/day after 3 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nadolol (240 mg/day after 3 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (1 week prior to intervention)
Number of subjects: 10
Study: 31025364

Group type: EXPERIMENTAL
Intervention: GuttaFlow Bioseal (GB)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BioRoot RCS (BR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Syringe irrigation (control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tornado Brush
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ultrasonically activated irrigation
Number of subjects: 36
Study: 28195139

Group type: EXPERIMENTAL
Intervention: MDMA-HCl (100 mg p.o.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (ascorbic acid)
Number of subjects: 25